Claseprubart
DNTH103-CIDP-301
Phase 3 small_molecule active
Quick answer
Claseprubart for Chronic Inflammatory Demyelinating Polyneuropathy is a Phase 3 program (small_molecule) at Dianthus Therapeutics, Inc. /DE/ with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dianthus Therapeutics, Inc. /DE/
- Indication
- Chronic Inflammatory Demyelinating Polyneuropathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active